How to Choose an ELISA Kit for Animal Samples: Species Reactivity, Sam

How to Choose an ELISA Kit for Animal Samples: Species Reactivity, Sample Type, Sensitivity and Cross-Reactivity

Selecting an ELISA kit for animal samples requires more than matching the name of a biomarker to a product catalogue. A kit may detect the correct analyte but still be unsuitable because it has not been validated for the intended species, biological matrix, concentration range or experimental conditions.

This is particularly important in animal research, where differences between species, sample matrices and collection procedures can substantially affect immunoassay performance. A kit validated for human serum cannot automatically be assumed to quantify the corresponding protein in mouse plasma, canine saliva or bovine milk.

A reliable selection process should answer four questions:

Does the assay recognize the analyte from the exact animal species?
Has the intended sample type been validated?
Does the assay range match the expected analyte concentration?
Could related proteins, other species or matrix components interfere with detection?

The strongest ELISA kit is therefore not necessarily the one with the lowest stated detection limit. It is the kit whose validation data most closely match the biological conditions of the study.

A reliable selection process should answer four questions:

Does the assay recognize the analyte from the exact animal species?
Has the intended sample type been validated?
Does the assay range match the expected analyte concentration?
Could related proteins, other species or matrix components interfere with detection?

The strongest ELISA kit is therefore not necessarily the one with the lowest stated detection limit. It is the kit whose validation data most closely match the biological conditions of the study.

How do you choose an ELISA kit for animal samples?

Choose an animal ELISA kit by confirming that the assay is validated for the exact species and biological matrix used in the experiment. Then compare the expected analyte concentration with the assay’s quantification range, assess molecular and cross-species reactivity, and review precision, recovery, dilution linearity, sample-volume requirements and potential matrix interference.

The Four-Gate Animal ELISA Selection Process

Gate 1: Confirm the Exact Animal Species

What does species reactivity mean in an ELISA kit?

Species reactivity indicates whether the antibodies used in the assay recognize the target analyte from a particular species.

Examples include:

Mouse IL-6
Rat TNF-α
Rabbit IgG
Canine CRP
Bovine progesterone
Porcine insulin
Equine cytokines
Chicken immunoglobulins
Zebrafish proteins

The name of a protein may be conserved across species, but the amino-acid sequence, three-dimensional structure, post-translational modifications and antibody-binding epitopes may differ.

For this reason, a kit labelled for human IL-6 should not be assumed to quantify mouse, rat or canine IL-6 unless the manufacturer provides supporting cross-species data.

-Validated, reactive and predicted are not equivalent

Product documentation may describe species compatibility in several ways.

-Validated for the species

The manufacturer has tested biological samples or recombinant analyte from that species and generated performance data.

This is the strongest evidence of suitability.

-Reported to react with the species

The antibodies appear to recognize the analyte, but the available validation may be limited to recombinant protein or a small number of samples.

The assay may be usable, but additional verification can be necessary.

-Predicted or expected reactivity

Reactivity is inferred from sequence similarity or other indirect evidence.

Predicted reactivity should not be treated as equivalent to experimental validation because antibody binding depends on the accessibility and structure of specific epitopes, not only on overall sequence identity.

Why protein homology is not enough?

Two species may share a high percentage of sequence similarity while differing at the exact antibody-binding site. Conversely, an antibody may recognize several related species despite lower overall sequence conservation.

Therefore, sequence homology can support a hypothesis of cross-species detection, but it cannot replace experimental evidence.

When the exact species is not listed, useful preliminary studies include:

Testing serial dilutions of representative samples
Comparing sample curves with the recombinant standard
Performing spike-and-recovery experiments
Assessing dilutional parallelism
Comparing results with another method
Testing positive and negative biological controls

Cross-species assay adaptation should be treated as a method-qualification exercise rather than a simple product substitution. Cross-species qualification studies commonly assess reactivity, matrix behaviour and parallelism before an assay validated in one species is applied to another.

Selection rule: Do not choose an ELISA kit solely because the target name is identical across species. Confirm that the exact animal species is supported by experimental data.

What does species reactivity mean in an ELISA kit?

Species reactivity indicates whether the antibodies used in the assay recognize the target analyte from a particular species.

Examples include:

Mouse IL-6
Rat TNF-α
Rabbit IgG
Canine CRP
Bovine progesterone
Porcine insulin
Equine cytokines
Chicken immunoglobulins
Zebrafish proteins

The name of a protein may be conserved across species, but the amino-acid sequence, three-dimensional structure, post-translational modifications and antibody-binding epitopes may differ.

For this reason, a kit labelled for human IL-6 should not be assumed to quantify mouse, rat or canine IL-6 unless the manufacturer provides supporting cross-species data.

-Validated, reactive and predicted are not equivalent

Product documentation may describe species compatibility in several ways.

-Validated for the species

The manufacturer has tested biological samples or recombinant analyte from that species and generated performance data.

This is the strongest evidence of suitability.

-Reported to react with the species

The antibodies appear to recognize the analyte, but the available validation may be limited to recombinant protein or a small number of samples.

The assay may be usable, but additional verification can be necessary.

-Predicted or expected reactivity

Reactivity is inferred from sequence similarity or other indirect evidence.

Why protein homology is not enough?

Therefore, sequence homology can support a hypothesis of cross-species detection, but it cannot replace experimental evidence.

When the exact species is not listed, useful preliminary studies include:

Testing serial dilutions of representative samples
Comparing sample curves with the recombinant standard
Performing spike-and-recovery experiments
Assessing dilutional parallelism
Comparing results with another method
Testing positive and negative biological controls

Selection rule: Do not choose an ELISA kit solely because the target name is identical across species. Confirm that the exact animal species is supported by experimental data.

Gate 2: Match the Kit to the Sample Type

Why does the biological matrix matter?

An ELISA does not measure an analyte in isolation. It measures the analyte within a complex biological environment.

Serum, plasma, tissue homogenate, urine, milk and cell-culture supernatant contain different concentrations of proteins, lipids, salts, enzymes, antibodies and other substances. These components can alter antibody binding, background signal, analyte recovery and the relationship between concentration and optical density.

Matrix effects can either suppress or enhance the measured signal, producing results that appear precise but are analytically inaccurate. Studies of biomarker immunoassays have shown that matrix composition can materially affect apparent assay sensitivity.

A kit should therefore be selected according to the exact sample matrix, not simply the target species.

Common animal sample types

- Serum :

Serum is obtained after blood has clotted. It does not contain the anticoagulant added to plasma tubes, but the clotting process can consume, release or modify some analytes.

Before selecting a serum ELISA kit, verify:

Whether serum is listed as a validated matrix
Recommended collection and clotting conditions
Centrifugation requirements
Expected sample dilution
Storage and freeze–thaw limitations
Potential interference from haemolysis or lipaemia

- Plasma :

Plasma is collected using an anticoagulant. Common anticoagulants include:

EDTA
Sodium citrate
Heparin

These plasma types should not automatically be treated as interchangeable. A kit may perform well with EDTA plasma but show lower recovery or greater background with heparin or citrate plasma.

Thermo Fisher’s sample-preparation guidance distinguishes anticoagulant-treated plasma from serum and notes that heparin may be unsuitable for some applications because it can introduce assay or biological effects.

A datasheet that lists “plasma” without identifying the validated anticoagulants should be reviewed carefully.

- Tissue homogenates :

Tissue samples present additional variability because the measured concentration depends on both biological abundance and extraction efficiency.

Important factors include:

Tissue type
Tissue mass
Homogenization method
Extraction-buffer composition
Presence of detergents
Protease or phosphatase inhibitors
Centrifugation conditions
Normalization method
Final sample dilution

A kit validated for serum may not perform correctly in liver, brain, muscle, tumour or intestinal homogenates. The extraction buffer may affect antibody binding or enzymatic signal generation.

When tissue homogenates are used, the results may need to be normalized to:

Total protein concentration
Tissue wet weight
Tissue dry weight
Cell number
Another experimentally justified reference

The selected normalization strategy should remain consistent throughout the study.

- Cell-culture supernatant :

Cell-culture supernatants are commonly used for secreted cytokines, chemokines, hormones and growth factors.

Before selection, consider:

Basal analyte concentration
Culture-medium composition
Serum supplementation
Phenol red
Treatment compounds
Cell density
Collection time
Sample dilution

Fetal bovine serum may contain endogenous proteins or cross-reactive components that contribute to background or interfere with recovery.

- Cell or tissue lysates :

Intracellular proteins require an assay validated for lysate samples. The lysis buffer must preserve the target while remaining compatible with the ELISA antibodies and detection chemistry.

Particular care is required for:

Phosphorylated proteins
Nuclear proteins
Membrane proteins
Protein complexes
Proteolytically unstable targets

A kit validated only for circulating samples may not be suitable for cell lysates.

- Urine :

Urine can vary considerably in:

pH
Ionic strength
Hydration-dependent dilution
Protein concentration
Collection conditions

Results may require normalization to creatinine, volume or another justified parameter.

- Saliva :

Saliva may contain mucins, digestive enzymes and variable amounts of blood contamination. Low target concentrations and viscosity can make dilution and recovery especially important.

- Milk :

Milk is a challenging immunoassay matrix because of its lipid and protein content. Species-specific validation, centrifugation, defatting, extraction and dilution procedures may be required.

Bronchoalveolar lavage fluid and other lavage samples

Lavage samples are diluted during collection. The measured concentration therefore reflects both biological abundance and the variable amount of fluid recovered.

- Cerebrospinal fluid :

Cerebrospinal fluid may contain low analyte concentrations and is often available only in limited volume. Sensitivity, sample-volume requirements and low-binding consumables can become major selection factors.

Commercial ELISA products illustrate why matrix validation must be explicit: different kits may list combinations such as serum, plasma, cell-culture supernatant, tissue homogenate, CSF, urine, saliva or milk, rather than claiming universal biological-fluid compatibility.

Why does the biological matrix matter?

An ELISA does not measure an analyte in isolation. It measures the analyte within a complex biological environment.

A kit should therefore be selected according to the exact sample matrix, not simply the target species.

Common animal sample types

- Serum :

Serum is obtained after blood has clotted. It does not contain the anticoagulant added to plasma tubes, but the clotting process can consume, release or modify some analytes.

Before selecting a serum ELISA kit, verify:

Whether serum is listed as a validated matrix
Recommended collection and clotting conditions
Centrifugation requirements
Expected sample dilution
Storage and freeze–thaw limitations
Potential interference from haemolysis or lipaemia

- Plasma :

Plasma is collected using an anticoagulant. Common anticoagulants include:

EDTA
Sodium citrate
Heparin

These plasma types should not automatically be treated as interchangeable. A kit may perform well with EDTA plasma but show lower recovery or greater background with heparin or citrate plasma.

A datasheet that lists “plasma” without identifying the validated anticoagulants should be reviewed carefully.

- Tissue homogenates :

Tissue samples present additional variability because the measured concentration depends on both biological abundance and extraction efficiency.

Important factors include:

Tissue type
Tissue mass
Homogenization method
Extraction-buffer composition
Presence of detergents
Protease or phosphatase inhibitors
Centrifugation conditions
Normalization method
Final sample dilution

A kit validated for serum may not perform correctly in liver, brain, muscle, tumour or intestinal homogenates. The extraction buffer may affect antibody binding or enzymatic signal generation.

When tissue homogenates are used, the results may need to be normalized to:

Total protein concentration
Tissue wet weight
Tissue dry weight
Cell number
Another experimentally justified reference

The selected normalization strategy should remain consistent throughout the study.

- Cell-culture supernatant :

Cell-culture supernatants are commonly used for secreted cytokines, chemokines, hormones and growth factors.

Before selection, consider:

Basal analyte concentration
Culture-medium composition
Serum supplementation
Phenol red
Treatment compounds
Cell density
Collection time
Sample dilution

Fetal bovine serum may contain endogenous proteins or cross-reactive components that contribute to background or interfere with recovery.

- Cell or tissue lysates :

Intracellular proteins require an assay validated for lysate samples. The lysis buffer must preserve the target while remaining compatible with the ELISA antibodies and detection chemistry.

Particular care is required for:

Phosphorylated proteins
Nuclear proteins
Membrane proteins
Protein complexes
Proteolytically unstable targets

A kit validated only for circulating samples may not be suitable for cell lysates.

- Urine :

Urine can vary considerably in:

pH
Ionic strength
Hydration-dependent dilution
Protein concentration
Collection conditions

Results may require normalization to creatinine, volume or another justified parameter.

- Saliva :

Saliva may contain mucins, digestive enzymes and variable amounts of blood contamination. Low target concentrations and viscosity can make dilution and recovery especially important.

- Milk :

Milk is a challenging immunoassay matrix because of its lipid and protein content. Species-specific validation, centrifugation, defatting, extraction and dilution procedures may be required.

Bronchoalveolar lavage fluid and other lavage samples

Lavage samples are diluted during collection. The measured concentration therefore reflects both biological abundance and the variable amount of fluid recovered.

- Cerebrospinal fluid :

Serum and Plasma Are Not the Same Matrix

Can a serum ELISA kit be used with plasma?

Sometimes, but only when plasma compatibility is supported by the datasheet or demonstrated experimentally.

Characteristic	Serum	Plasma
Collection	Blood allowed to clot	Blood collected with anticoagulant
Clotting factors	Largely consumed or removed	Retained
Anticoagulant	None	EDTA, citrate, heparin or another agent
Possible assay impact	Changes caused by clotting	Anticoagulant-specific effects
Interchangeability	Not automatic	Plasma types are not automatically interchangeable

An assay validated in serum may show different recovery in EDTA, citrate or heparin plasma. Manufacturer data sometimes report separate recovery values for each matrix, demonstrating that matrix type can alter measured performance.

When both serum and plasma samples are included in one study, they should not be combined into a single analytical group without evidence that the results are comparable.

Serum and Plasma Are Not the Same Matrix

Can a serum ELISA kit be used with plasma?

Sometimes, but only when plasma compatibility is supported by the datasheet or demonstrated experimentally.

Characteristic	Serum	Plasma
Collection	Blood allowed to clot	Blood collected with anticoagulant
Clotting factors	Largely consumed or removed	Retained
Anticoagulant	None	EDTA, citrate, heparin or another agent
Possible assay impact	Changes caused by clotting	Anticoagulant-specific effects
Interchangeability	Not automatic	Plasma types are not automatically interchangeable

When both serum and plasma samples are included in one study, they should not be combined into a single analytical group without evidence that the results are comparable.

Gate 3: Match Sensitivity and Assay Range to the Samples

What does ELISA sensitivity mean?

Sensitivity is often reported as the minimum detectable dose or limit of detection. It describes the smallest signal that can be distinguished from the assay background under specified conditions.

However, the detection limit is not necessarily the lowest concentration that can be quantified reliably.

Researchers should distinguish among:

-Limit of detection :

The lowest analyte concentration distinguishable from the zero or blank response.

-Lower limit of quantification :

The lowest concentration that can be quantified with acceptable analytical performance.

-Upper limit of quantification :

The highest concentration that can be quantified reliably without unacceptable nonlinearity or saturation.

-Standard-curve range :

The concentration interval represented by the standards supplied with the kit.

-Validated working range :

The interval over which acceptable performance has been demonstrated for the intended method and matrix.

Why the lowest detection limit is not always best ?

Suppose the expected analyte concentration is between 300 and 800 pg/mL.

Kit A has a standard range of 5–200 pg/mL.
Kit B has a standard range of 50–2,000 pg/mL.

Although Kit A may appear more sensitive, Kit B is likely to provide a more practical starting range. Kit A would require greater sample dilution, and those dilutions would need to behave predictably.

The best assay places most expected samples comfortably within the central portion of the quantification range rather than near the lowest or highest standard.

What happens when a sample is above the assay range?

Samples above the upper limit should normally be diluted using the recommended sample diluent and retested.

However, dilution is reliable only when the sample demonstrates dilutional linearity or parallelism. A sample that changes disproportionately after dilution may be affected by matrix interference, analyte-binding proteins or differences between the natural analyte and the kit standard.

-The high-dose hook effect :

In some sandwich immunoassays, an extremely high analyte concentration can produce a falsely low result. This is known as the high-dose hook or prozone effect.

A suspiciously low value from a sample expected to contain a very high analyte concentration should therefore be retested at several dilutions.

FDA bioanalytical guidance for ligand-binding assays specifically identifies dilution linearity and absence of a prozone effect as relevant validation considerations.

Selection rule: Choose an ELISA range that matches the expected biological concentration. Do not rank kits only by the smallest stated detection limit.

What does ELISA sensitivity mean?

Sensitivity is often reported as the minimum detectable dose or limit of detection. It describes the smallest signal that can be distinguished from the assay background under specified conditions.

However, the detection limit is not necessarily the lowest concentration that can be quantified reliably.

Researchers should distinguish among:

-Limit of detection :

The lowest analyte concentration distinguishable from the zero or blank response.

-Lower limit of quantification :

The lowest concentration that can be quantified with acceptable analytical performance.

-Upper limit of quantification :

The highest concentration that can be quantified reliably without unacceptable nonlinearity or saturation.

-Standard-curve range :

The concentration interval represented by the standards supplied with the kit.

-Validated working range :

The interval over which acceptable performance has been demonstrated for the intended method and matrix.

Why the lowest detection limit is not always best ?

Suppose the expected analyte concentration is between 300 and 800 pg/mL.

Kit A has a standard range of 5–200 pg/mL.
Kit B has a standard range of 50–2,000 pg/mL.

The best assay places most expected samples comfortably within the central portion of the quantification range rather than near the lowest or highest standard.

What happens when a sample is above the assay range?

Samples above the upper limit should normally be diluted using the recommended sample diluent and retested.

-The high-dose hook effect :

In some sandwich immunoassays, an extremely high analyte concentration can produce a falsely low result. This is known as the high-dose hook or prozone effect.

A suspiciously low value from a sample expected to contain a very high analyte concentration should therefore be retested at several dilutions.

FDA bioanalytical guidance for ligand-binding assays specifically identifies dilution linearity and absence of a prozone effect as relevant validation considerations.

Selection rule: Choose an ELISA range that matches the expected biological concentration. Do not rank kits only by the smallest stated detection limit.

Gate 4: Evaluate Specificity and Cross-Reactivity

What is ELISA specificity?

Specificity describes the assay’s ability to measure the intended analyte without significant contribution from other substances.

In an animal ELISA, specificity should be considered at several levels.

1. Species reactivity :

Does the assay detect the intended analyte from the selected species?

Example:

Does a mouse IL-1α kit recognize mouse IL-1α?

2. Cross-species reactivity :

Does the assay also recognize the corresponding analyte from another species?

Example:

Does a human cytokine kit detect the canine or primate ortholog?

Cross-species reactivity may be useful when an exact species-specific kit is unavailable. It may also become a source of unwanted signal when samples contain proteins from more than one species.

3. Molecular cross-reactivity :

Do the antibodies bind structurally related molecules?

Potential sources include:

Protein-family members
Isoforms
Precursors
Cleavage products
Receptors
Binding proteins
Closely related hormones
Related cytokines

Manufacturers may report cross-reactivity by testing related molecules at defined concentrations. Some commercial immunoassays separately report molecular cross-reactivity and cross-species reactivity, showing that these are distinct analytical questions.

4. Interference :

A substance may alter the assay result without being interpreted as the target analyte.

Possible interfering factors include:

Heterophilic antibodies
Rheumatoid-factor-like antibodies
Anti-reagent antibodies
Endogenous immunoglobulins
Haemoglobin
Lipids
Bilirubin
Complement proteins
Soluble receptors
Analyte-binding proteins
Therapeutic antibodies
Collection-tube additives
Extraction-buffer components

Interfering antibodies are not restricted to human clinical samples. A study of canine and feline sera demonstrated that animal samples can contain substances reacting with mammalian immunoglobulin reagents and capable of producing immunoassay interference.

Cross-reactivity data have limits

A statement such as “no significant cross-reactivity observed” normally means that no significant signal was detected among the specific substances tested.

It does not prove that the assay has been evaluated against every possible protein, species, medication or biological condition.

Researchers should review:

Which related molecules were tested
At what concentrations they were tested
Which species were included
Whether interference or true cross-reactivity was evaluated
Whether natural and recombinant forms were assessed

What is ELISA specificity?

Specificity describes the assay’s ability to measure the intended analyte without significant contribution from other substances.

In an animal ELISA, specificity should be considered at several levels.

1. Species reactivity :

Does the assay detect the intended analyte from the selected species?

Example:

Does a mouse IL-1α kit recognize mouse IL-1α?

2. Cross-species reactivity :

Does the assay also recognize the corresponding analyte from another species?

Example:

Does a human cytokine kit detect the canine or primate ortholog?

Cross-species reactivity may be useful when an exact species-specific kit is unavailable. It may also become a source of unwanted signal when samples contain proteins from more than one species.

3. Molecular cross-reactivity :

Do the antibodies bind structurally related molecules?

Potential sources include:

Protein-family members
Isoforms
Precursors
Cleavage products
Receptors
Binding proteins
Closely related hormones
Related cytokines

4. Interference :

A substance may alter the assay result without being interpreted as the target analyte.

Possible interfering factors include:

Heterophilic antibodies
Rheumatoid-factor-like antibodies
Anti-reagent antibodies
Endogenous immunoglobulins
Haemoglobin
Lipids
Bilirubin
Complement proteins
Soluble receptors
Analyte-binding proteins
Therapeutic antibodies
Collection-tube additives
Extraction-buffer components

Cross-reactivity data have limits

A statement such as “no significant cross-reactivity observed” normally means that no significant signal was detected among the specific substances tested.

It does not prove that the assay has been evaluated against every possible protein, species, medication or biological condition.

Researchers should review:

Which related molecules were tested
At what concentrations they were tested
Which species were included
Whether interference or true cross-reactivity was evaluated
Whether natural and recombinant forms were assessed

Consider the ELISA Format

Sandwich ELISA

A sandwich ELISA uses two antibodies that bind different epitopes on the target.

It is generally appropriate for:

Cytokines
Chemokines
Growth factors
Large hormones
Immunoglobulins
Soluble receptors
Many protein biomarkers

Sandwich assays can offer high specificity because two binding events are required. However, they depend on the target having at least two accessible epitopes.

Sandwich ELISA

A sandwich ELISA uses two antibodies that bind different epitopes on the target.

It is generally appropriate for:

Cytokines
Chemokines
Growth factors
Large hormones
Immunoglobulins
Soluble receptors
Many protein biomarkers

Sandwich assays can offer high specificity because two binding events are required. However, they depend on the target having at least two accessible epitopes.

Competitive ELISA

A competitive ELISA measures competition between sample analyte and a labelled or plate-bound analyte.

It is often used for:

Steroid hormones
Small molecules
Lipids
Metabolites
Peptides
Analytes with only one accessible antibody-binding site

In a competitive assay, the relationship between analyte concentration and signal is usually inverse: more analyte produces less signal.

Competitive ELISA

A competitive ELISA measures competition between sample analyte and a labelled or plate-bound analyte.

It is often used for:

Steroid hormones
Small molecules
Lipids
Metabolites
Peptides
Analytes with only one accessible antibody-binding site

In a competitive assay, the relationship between analyte concentration and signal is usually inverse: more analyte produces less signal.

Indirect ELISA

Indirect ELISA is commonly used to detect antibodies against a particular antigen.

Applications may include:

Serology
Vaccine-response studies
Infectious-disease research
Autoantibody studies
Exposure studies

In antibody-detection assays, the secondary antibody must be appropriate for the immunoglobulin class and animal species being tested.

A human anti-IgG conjugate, for example, cannot be assumed to detect mouse, rabbit, bovine or canine immunoglobulins appropriately.

Indirect ELISA

Indirect ELISA is commonly used to detect antibodies against a particular antigen.

Applications may include:

Serology
Vaccine-response studies
Infectious-disease research
Autoantibody studies
Exposure studies

In antibody-detection assays, the secondary antibody must be appropriate for the immunoglobulin class and animal species being tested.

A human anti-IgG conjugate, for example, cannot be assumed to detect mouse, rabbit, bovine or canine immunoglobulins appropriately.

A Step-by-Step Animal ELISA Kit Selection Checklist

Practical Selection Scenarios

Scenario 1: Measuring a mouse cytokine in serum

The researcher should verify:

Mouse-specific reactivity
Serum validation
Expected cytokine concentration
Required dilution
Cross-reactivity with related cytokines
Recovery in mouse serum
Precision near the expected concentration

A highly sensitive kit may be needed for basal cytokine concentrations, while stimulated or inflammatory models may require a wider upper range.

Scenario 1: Measuring a mouse cytokine in serum

The researcher should verify:

Mouse-specific reactivity
Serum validation
Expected cytokine concentration
Required dilution
Cross-reactivity with related cytokines
Recovery in mouse serum
Precision near the expected concentration

A highly sensitive kit may be needed for basal cytokine concentrations, while stimulated or inflammatory models may require a wider upper range.

Scenario 2: Measuring a rat biomarker in brain homogenate

The researcher should verify:

Mouse-specific reactivity
Serum validation
Expected cytokine concentration
Required dilution
Cross-reactivity with related cytokines
Recovery in mouse serum
Precision near the expected concentration

A highly sensitive kit may be needed for basal cytokine concentrations, while stimulated or inflammatory models may require a wider upper range.

Scenario 2: Measuring a rat biomarker in brain homogenate

The researcher should verify:

Mouse-specific reactivity
Serum validation
Expected cytokine concentration
Required dilution
Cross-reactivity with related cytokines
Recovery in mouse serum
Precision near the expected concentration

A highly sensitive kit may be needed for basal cytokine concentrations, while stimulated or inflammatory models may require a wider upper range.

Seven Reasons Not to Choose an ELISA Kit

Do not select a kit when:

The exact animal species is not listed and no cross-species evidence is available.
The intended biological matrix has not been validated.
The expected concentration is outside the assay’s useful range.
Only a detection limit is reported, with no meaningful quantification-range information.
Cross-reactivity and interference data are absent.
Recovery, dilution linearity or precision data are missing.
The required sample volume is impractical for the study.

Do not select a kit when:

The exact animal species is not listed and no cross-species evidence is available.
The intended biological matrix has not been validated.
The expected concentration is outside the assay’s useful range.
Only a detection limit is reported, with no meaningful quantification-range information.
Cross-reactivity and interference data are absent.
Recovery, dilution linearity or precision data are missing.
The required sample volume is impractical for the study.

Additional warning signs include :

Unclear standard composition
No distinction between serum and plasma
No information about anticoagulants
No representative standard curve
No storage information
No lot traceability
No positive sample data
Vague claims such as “high sensitivity” without supporting values

Additional warning signs include :

Unclear standard composition
No distinction between serum and plasma
No information about anticoagulants
No representative standard curve
No storage information
No lot traceability
No positive sample data
Vague claims such as “high sensitivity” without supporting values

Frequently asked questions

Can a human ELISA kit be used for animal samples?+

Only when the antibodies have demonstrated reactivity with the animal analyte and the relevant animal matrix has been qualified. Sequence similarity alone does not confirm assay suitability.

What does species reactivity mean?+

Species reactivity describes the species from which the assay can recognize the target analyte. It should be supported by experimental data rather than assumed from the protein name.

Is cross-species reactivity the same as cross-reactivity?+

No. Cross-species reactivity refers to recognition of the corresponding analyte from another species. Molecular cross-reactivity refers to unintended recognition of related proteins or other molecules.

Can the same kit be used for mouse and rat samples?+

Only when both species are explicitly validated or supported by cross-species studies. Mouse and rat proteins are related, but their antibody-binding epitopes may differ.

Can a serum ELISA kit be used with plasma?+

Only when the relevant plasma type has been validated or qualified. EDTA, citrate and heparin plasma can behave differently.

Can tissue homogenates be tested with any ELISA kit?+

No. The kit should be validated for tissue extracts or independently qualified for the intended tissue and extraction buffer.

How sensitive should an animal ELISA kit be?+

The assay should be sensitive enough to quantify the expected sample concentrations, but its range should also extend high enough to avoid excessive dilution. The lowest detection limit is not automatically the best choice.

What is matrix interference?+

Matrix interference occurs when components of the biological sample alter the measured signal independently of the actual analyte concentration.

What is spike recovery?+

Spike recovery measures how much of a known amount of added analyte can be detected after it is introduced into a biological sample.

What is dilutional parallelism?+

Parallelism evaluates whether serially diluted samples produce a response curve that behaves similarly to the standard curve.

Should samples be tested in duplicate?+

Technical duplicates are commonly used to identify pipetting errors and evaluate within-run consistency. More replicates may be required for method development or low-abundance measurements.

Can results from different ELISA kit brands be compared directly?+

Not necessarily. Kits may use different antibody pairs, standards, calibration models and recognized epitopes. Absolute concentrations can therefore differ even when the same samples are tested.